| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 1.27e-06 | 37 | 103 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 1.32e-06 | 5 | 103 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 1.45e-06 | 38 | 103 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 2.13e-05 | 11 | 103 | 3 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 4.66e-05 | 14 | 103 | 3 | GO:0003964 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | SPTAN1 CCDC187 GOLGA6A KIF7 TAOK2 FMNL3 SPTBN5 SYNE3 DST LMO7 MICAL2 STARD9 SYNE2 DAAM2 KIF5B UTRN | 1.55e-04 | 1099 | 103 | 16 | GO:0008092 |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.66e-04 | 21 | 103 | 3 | GO:0035613 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 2.61e-04 | 5 | 103 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | NAD+-protein-cysteine ADP-ribosyltransferase activity | 3.90e-04 | 6 | 103 | 2 | GO:0140803 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 4.71e-04 | 70 | 103 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | structural molecule activity | KRT72 ERVK-6 KRT1 SPTAN1 LAMA3 MRPL52 ERVK-7 CCDC6 KRT73 DST ERVK-8 ERVK-19 ERVK-25 | 6.64e-04 | 891 | 103 | 13 | GO:0005198 |
| GeneOntologyMolecularFunction | actin binding | 8.34e-04 | 479 | 103 | 9 | GO:0003779 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 9.12e-04 | 37 | 103 | 3 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 9.86e-04 | 38 | 103 | 3 | GO:0034061 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 1.15e-03 | 152 | 103 | 5 | GO:0016779 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 1.42e-03 | 43 | 103 | 3 | GO:0030280 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 1.62e-03 | 45 | 103 | 3 | GO:0043495 | |
| GeneOntologyMolecularFunction | nuclear export signal receptor activity | 1.68e-03 | 12 | 103 | 2 | GO:0005049 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.72e-03 | 46 | 103 | 3 | GO:0016893 | |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | 1.73e-03 | 532 | 103 | 9 | GO:0016755 | |
| GeneOntologyMolecularFunction | ubiquitin-ubiquitin ligase activity | 2.30e-03 | 14 | 103 | 2 | GO:0034450 | |
| GeneOntologyMolecularFunction | pentosyltransferase activity | 3.03e-03 | 56 | 103 | 3 | GO:0016763 | |
| GeneOntologyMolecularFunction | ubiquitin-protein transferase activity | 3.12e-03 | 473 | 103 | 8 | GO:0004842 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.27e-03 | 118 | 103 | 4 | GO:0003774 | |
| GeneOntologyBiologicalProcess | DNA integration | 3.24e-05 | 13 | 102 | 3 | GO:0015074 | |
| GeneOntologyBiologicalProcess | positive regulation of smoothened signaling pathway | 7.19e-05 | 45 | 102 | 4 | GO:0045880 | |
| GeneOntologyBiologicalProcess | development of secondary male sexual characteristics | 7.24e-05 | 3 | 102 | 2 | GO:0046544 | |
| GeneOntologyCellularComponent | manchette | 1.04e-05 | 28 | 103 | 4 | GO:0002177 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.47e-04 | 161 | 103 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | microtubule organizing center | TCHP HAUS5 EVC CCDC187 KIF7 UBXN2B PROSER3 STARD9 ITSN2 SASS6 CEP131 KIF5B CCDC65 NEURL4 | 1.65e-04 | 919 | 103 | 14 | GO:0005815 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 3.27e-04 | 263 | 103 | 7 | GO:0045111 | |
| GeneOntologyCellularComponent | nuclear envelope | 4.45e-04 | 560 | 103 | 10 | GO:0005635 | |
| GeneOntologyCellularComponent | cilium | TCHP DYNC2H1 RAPGEF4 EVC NUP42 QRICH2 KIF7 SPTBN5 CEP131 KIF5B CCDC65 WDR49 DRC3 | 4.66e-04 | 898 | 103 | 13 | GO:0005929 |
| GeneOntologyCellularComponent | spectrin | 8.46e-04 | 9 | 103 | 2 | GO:0008091 | |
| GeneOntologyCellularComponent | apical cortex | 1.05e-03 | 10 | 103 | 2 | GO:0045179 | |
| GeneOntologyCellularComponent | microtubule organizing center attachment site | 1.28e-03 | 11 | 103 | 2 | GO:0034992 | |
| GeneOntologyCellularComponent | hemidesmosome | 1.28e-03 | 11 | 103 | 2 | GO:0030056 | |
| GeneOntologyCellularComponent | meiotic nuclear membrane microtubule tethering complex | 1.28e-03 | 11 | 103 | 2 | GO:0034993 | |
| GeneOntologyCellularComponent | nuclear membrane protein complex | 1.28e-03 | 11 | 103 | 2 | GO:0106083 | |
| GeneOntologyCellularComponent | nuclear membrane microtubule tethering complex | 1.28e-03 | 11 | 103 | 2 | GO:0106094 | |
| GeneOntologyCellularComponent | keratin filament | 1.36e-03 | 97 | 103 | 4 | GO:0045095 | |
| GeneOntologyCellularComponent | nuclear membrane | 1.71e-03 | 349 | 103 | 7 | GO:0031965 | |
| GeneOntologyCellularComponent | cytoplasmic region | 2.04e-03 | 360 | 103 | 7 | GO:0099568 | |
| MousePheno | abnormal sperm nucleus morphology | 3.40e-06 | 74 | 78 | 6 | MP:0009232 | |
| MousePheno | disorganized suprabasal layer | 3.07e-05 | 2 | 78 | 2 | MP:0001235 | |
| MousePheno | detached acrosome | 1.03e-04 | 44 | 78 | 4 | MP:0009231 | |
| MousePheno | abnormal craniofacial morphology | AKAP6 TCHP DYNC2H1 SPTAN1 LAMA3 EVC HESX1 TIPARP KIF7 HOXA3 DST HOXD3 UBR5 GORAB LRRC8A SASS6 DAAM2 PEAK1 MED12 | 1.47e-04 | 1372 | 78 | 19 | MP:0000428 |
| MousePheno | craniofacial phenotype | AKAP6 TCHP DYNC2H1 SPTAN1 LAMA3 EVC HESX1 TIPARP KIF7 HOXA3 DST HOXD3 UBR5 GORAB LRRC8A SASS6 DAAM2 PEAK1 MED12 | 1.47e-04 | 1372 | 78 | 19 | MP:0005382 |
| MousePheno | ectopic manchette | 1.52e-04 | 19 | 78 | 3 | MP:0009377 | |
| Domain | Spectrin/alpha-actinin | 2.13e-10 | 32 | 95 | 7 | IPR018159 | |
| Domain | SPEC | 2.13e-10 | 32 | 95 | 7 | SM00150 | |
| Domain | Spectrin | 1.39e-09 | 23 | 95 | 6 | PF00435 | |
| Domain | Spectrin_repeat | 6.38e-09 | 29 | 95 | 6 | IPR002017 | |
| Domain | CH | 9.57e-07 | 65 | 95 | 6 | SM00033 | |
| Domain | CH | 1.49e-06 | 70 | 95 | 6 | PF00307 | |
| Domain | - | 1.62e-06 | 71 | 95 | 6 | 1.10.418.10 | |
| Domain | CH | 1.91e-06 | 73 | 95 | 6 | PS50021 | |
| Domain | EF-hand-dom_pair | FSTL5 SPTAN1 STAT4 STAT5A STAT5B DST MRPS26 ITSN2 NECAB3 UTRN | 2.01e-06 | 287 | 95 | 10 | IPR011992 |
| Domain | CH-domain | 2.24e-06 | 75 | 95 | 6 | IPR001715 | |
| Domain | STAT_TF_prot_interaction | 4.40e-06 | 7 | 95 | 3 | IPR013799 | |
| Domain | STAT_TF_DNA-bd_sub | 4.40e-06 | 7 | 95 | 3 | IPR012345 | |
| Domain | STAT | 4.40e-06 | 7 | 95 | 3 | IPR001217 | |
| Domain | STAT_TF_coiled-coil | 4.40e-06 | 7 | 95 | 3 | IPR015988 | |
| Domain | - | 4.40e-06 | 7 | 95 | 3 | 2.60.40.630 | |
| Domain | STAT_int | 4.40e-06 | 7 | 95 | 3 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 4.40e-06 | 7 | 95 | 3 | IPR013801 | |
| Domain | STAT_bind | 4.40e-06 | 7 | 95 | 3 | PF02864 | |
| Domain | STAT_int | 4.40e-06 | 7 | 95 | 3 | PF02865 | |
| Domain | - | 4.40e-06 | 7 | 95 | 3 | 1.10.532.10 | |
| Domain | STAT_alpha | 4.40e-06 | 7 | 95 | 3 | PF01017 | |
| Domain | - | 4.40e-06 | 7 | 95 | 3 | 1.20.1050.20 | |
| Domain | Actinin_actin-bd_CS | 5.16e-06 | 23 | 95 | 4 | IPR001589 | |
| Domain | ACTININ_2 | 5.16e-06 | 23 | 95 | 4 | PS00020 | |
| Domain | ACTININ_1 | 5.16e-06 | 23 | 95 | 4 | PS00019 | |
| Domain | STAT_TF_alpha | 7.01e-06 | 8 | 95 | 3 | IPR013800 | |
| Domain | - | 7.30e-06 | 261 | 95 | 9 | 1.10.238.10 | |
| Domain | Mediator_Med12 | 2.56e-05 | 2 | 95 | 2 | IPR019035 | |
| Domain | Med12 | 2.56e-05 | 2 | 95 | 2 | PF09497 | |
| Domain | Mediator_Med12_LCEWAV | 2.56e-05 | 2 | 95 | 2 | IPR021990 | |
| Domain | Mediator_Med12_catenin-bd | 2.56e-05 | 2 | 95 | 2 | IPR021989 | |
| Domain | Med12-PQL | 2.56e-05 | 2 | 95 | 2 | PF12144 | |
| Domain | Med12-LCEWAV | 2.56e-05 | 2 | 95 | 2 | PF12145 | |
| Domain | Med12 | 2.56e-05 | 2 | 95 | 2 | SM01281 | |
| Domain | DUF4074 | 7.65e-05 | 3 | 95 | 2 | IPR025281 | |
| Domain | DUF4074 | 7.65e-05 | 3 | 95 | 2 | PF13293 | |
| Domain | GOLGA2L5 | 9.84e-05 | 18 | 95 | 3 | PF15070 | |
| Domain | Golgin_A | 9.84e-05 | 18 | 95 | 3 | IPR024858 | |
| Domain | SH3 | 1.17e-04 | 216 | 95 | 7 | PS50002 | |
| Domain | SH3_domain | 1.31e-04 | 220 | 95 | 7 | IPR001452 | |
| Domain | KASH | 1.53e-04 | 4 | 95 | 2 | PF10541 | |
| Domain | KASH | 1.53e-04 | 4 | 95 | 2 | IPR012315 | |
| Domain | KASH | 1.53e-04 | 4 | 95 | 2 | PS51049 | |
| Domain | KASH | 1.53e-04 | 4 | 95 | 2 | SM01249 | |
| Domain | zf-CCHC | 2.10e-04 | 23 | 95 | 3 | PF00098 | |
| Domain | Keratin_2_head | 2.39e-04 | 24 | 95 | 3 | IPR032444 | |
| Domain | Keratin_2_head | 2.39e-04 | 24 | 95 | 3 | PF16208 | |
| Domain | SH2 | 2.46e-04 | 110 | 95 | 5 | SM00252 | |
| Domain | SH2 | 2.56e-04 | 111 | 95 | 5 | PS50001 | |
| Domain | SH2 | 2.67e-04 | 112 | 95 | 5 | IPR000980 | |
| Domain | - | 2.67e-04 | 112 | 95 | 5 | 3.30.505.10 | |
| Domain | Keratin_II | 3.04e-04 | 26 | 95 | 3 | IPR003054 | |
| Domain | GOLGA6L | 3.79e-04 | 6 | 95 | 2 | IPR026737 | |
| Domain | SH3_9 | 6.72e-04 | 78 | 95 | 4 | PF14604 | |
| Domain | VPS9 | 7.03e-04 | 8 | 95 | 2 | SM00167 | |
| Domain | ZF_CCHC | 7.42e-04 | 35 | 95 | 3 | PS50158 | |
| Domain | SH3 | 8.25e-04 | 216 | 95 | 6 | SM00326 | |
| Domain | Drf_GBD | 9.00e-04 | 9 | 95 | 2 | PF06371 | |
| Domain | FH3_dom | 9.00e-04 | 9 | 95 | 2 | IPR010472 | |
| Domain | GTPase-bd | 9.00e-04 | 9 | 95 | 2 | IPR010473 | |
| Domain | Drf_FH3 | 9.00e-04 | 9 | 95 | 2 | PF06367 | |
| Domain | Drf_FH3 | 9.00e-04 | 9 | 95 | 2 | SM01139 | |
| Domain | Drf_GBD | 9.00e-04 | 9 | 95 | 2 | SM01140 | |
| Domain | SH3_2 | 9.70e-04 | 86 | 95 | 4 | IPR011511 | |
| Domain | SH3_2 | 9.70e-04 | 86 | 95 | 4 | PF07653 | |
| Domain | EF-hand_1 | 1.08e-03 | 152 | 95 | 5 | PF00036 | |
| Domain | VPS9 | 1.12e-03 | 10 | 95 | 2 | PS51205 | |
| Domain | VPS9 | 1.12e-03 | 10 | 95 | 2 | PF02204 | |
| Domain | VPS9 | 1.12e-03 | 10 | 95 | 2 | IPR003123 | |
| Domain | Kinesin_motor_CS | 1.18e-03 | 41 | 95 | 3 | IPR019821 | |
| Domain | GBD/FH3_dom | 1.37e-03 | 11 | 95 | 2 | IPR014768 | |
| Domain | GBD_FH3 | 1.37e-03 | 11 | 95 | 2 | PS51232 | |
| Domain | KINESIN_MOTOR_1 | 1.45e-03 | 44 | 95 | 3 | PS00411 | |
| Domain | - | 1.45e-03 | 44 | 95 | 3 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 1.45e-03 | 44 | 95 | 3 | IPR001752 | |
| Domain | Kinesin | 1.45e-03 | 44 | 95 | 3 | PF00225 | |
| Domain | KINESIN_MOTOR_2 | 1.45e-03 | 44 | 95 | 3 | PS50067 | |
| Domain | KISc | 1.45e-03 | 44 | 95 | 3 | SM00129 | |
| Domain | WWE | 1.63e-03 | 12 | 95 | 2 | PS50918 | |
| Domain | WWE | 1.63e-03 | 12 | 95 | 2 | PF02825 | |
| Domain | WWE-dom | 1.63e-03 | 12 | 95 | 2 | IPR004170 | |
| Domain | SH2 | 1.76e-03 | 101 | 95 | 4 | PF00017 | |
| Domain | EF_Hand_1_Ca_BS | 2.00e-03 | 175 | 95 | 5 | IPR018247 | |
| Domain | p53-like_TF_DNA-bd | 2.48e-03 | 53 | 95 | 3 | IPR008967 | |
| Domain | Spectrin_alpha_SH3 | 2.57e-03 | 15 | 95 | 2 | IPR013315 | |
| Domain | FH2 | 2.57e-03 | 15 | 95 | 2 | PS51444 | |
| Domain | FH2_Formin | 2.57e-03 | 15 | 95 | 2 | IPR015425 | |
| Domain | FH2 | 2.57e-03 | 15 | 95 | 2 | PF02181 | |
| Domain | FH2 | 2.57e-03 | 15 | 95 | 2 | SM00498 | |
| Domain | ZnF_C2HC | 2.76e-03 | 55 | 95 | 3 | SM00343 | |
| Domain | Znf_CCHC | 2.76e-03 | 55 | 95 | 3 | IPR001878 | |
| Domain | Poly(ADP-ribose)pol_cat_dom | 3.31e-03 | 17 | 95 | 2 | IPR012317 | |
| Domain | PARP_CATALYTIC | 3.31e-03 | 17 | 95 | 2 | PS51059 | |
| Domain | PARP | 3.31e-03 | 17 | 95 | 2 | PF00644 | |
| Domain | - | 3.31e-03 | 17 | 95 | 2 | 3.90.228.10 | |
| Domain | EF_HAND_1 | 3.87e-03 | 204 | 95 | 5 | PS00018 | |
| Domain | Intermediate_filament_CS | 4.06e-03 | 63 | 95 | 3 | IPR018039 | |
| Domain | Homeobox_Antennapedia_CS | 5.05e-03 | 21 | 95 | 2 | IPR001827 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 1.37e-05 | 10 | 70 | 3 | M27898 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 4.02e-05 | 39 | 70 | 4 | MM15607 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 4.45e-05 | 40 | 70 | 4 | M41816 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 2.41e-04 | 5 | 70 | 2 | M48987 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY | 2.41e-04 | 5 | 70 | 2 | M48986 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY | 2.41e-04 | 5 | 70 | 2 | M49006 | |
| Pathway | REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING | 2.81e-04 | 26 | 70 | 3 | M27750 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 3.60e-04 | 6 | 70 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 3.60e-04 | 6 | 70 | 2 | MM15621 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 5.02e-04 | 7 | 70 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY | 5.02e-04 | 7 | 70 | 2 | M47581 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY | 5.02e-04 | 7 | 70 | 2 | M47646 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 5.02e-04 | 7 | 70 | 2 | M47430 | |
| Pathway | REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5 | 5.02e-04 | 7 | 70 | 2 | M27907 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 8.07e-04 | 37 | 70 | 3 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 8.07e-04 | 37 | 70 | 3 | MM15610 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 8.56e-04 | 9 | 70 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 8.56e-04 | 9 | 70 | 2 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 8.56e-04 | 9 | 70 | 2 | M8066 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 1.07e-03 | 10 | 70 | 2 | MM15112 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 1.07e-03 | 10 | 70 | 2 | M41731 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 1.07e-03 | 10 | 70 | 2 | MM15618 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 1.30e-03 | 11 | 70 | 2 | M27372 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 1.30e-03 | 11 | 70 | 2 | M27195 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 1.30e-03 | 11 | 70 | 2 | MM15578 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 1.34e-03 | 44 | 70 | 3 | M1012 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY | 1.43e-03 | 45 | 70 | 3 | M47408 | |
| Pathway | WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY | 1.53e-03 | 46 | 70 | 3 | M39828 | |
| Pathway | REACTOME_INTERLEUKIN_2_SIGNALING | 1.55e-03 | 12 | 70 | 2 | M27893 | |
| Pathway | WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING | 1.63e-03 | 47 | 70 | 3 | M39380 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY | 2.13e-03 | 14 | 70 | 2 | M47414 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 2.13e-03 | 14 | 70 | 2 | M27858 | |
| Pathway | PID_IL5_PATHWAY | 2.13e-03 | 14 | 70 | 2 | M135 | |
| Pathway | PID_PTP1B_PATHWAY | 2.18e-03 | 52 | 70 | 3 | M50 | |
| Pathway | WP_FOXP3_IN_COVID19 | 2.45e-03 | 15 | 70 | 2 | M42573 | |
| Pathway | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | 2.45e-03 | 15 | 70 | 2 | M552 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 2.45e-03 | 15 | 70 | 2 | MM1412 | |
| Pathway | BIOCARTA_IL3_PATHWAY | 2.45e-03 | 15 | 70 | 2 | M17681 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 2.45e-03 | 15 | 70 | 2 | MM14536 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | TFEB KRT1 TCHP DYNC2H1 TNIP1 NUP42 CCDC6 RAD50 RIMBP3 UBR5 LMO7 SASS6 CEP131 PPP6R3 | 2.99e-09 | 588 | 105 | 14 | 38580884 |
| Pubmed | GAPVD1 TCHP SPTAN1 SAV1 CCDC6 KIF7 DST UBR5 LMO7 CEP131 UTRN PPP6R3 | 1.14e-08 | 446 | 105 | 12 | 24255178 | |
| Pubmed | 2.97e-08 | 225 | 105 | 9 | 12168954 | ||
| Pubmed | Allograft rejection requires STAT5a/b-regulated antiapoptotic activity in T cells but not B cells. | 1.07e-07 | 4 | 105 | 3 | 16365403 | |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 1.07e-07 | 4 | 105 | 3 | 19091768 | |
| Pubmed | 2.52e-07 | 209 | 105 | 8 | 36779422 | ||
| Pubmed | The Current STATus of lymphocyte signaling: new roles for old players. | 2.66e-07 | 5 | 105 | 3 | 19362457 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 2.66e-07 | 5 | 105 | 3 | 12629516 | |
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 2.66e-07 | 5 | 105 | 3 | 17855024 | |
| Pubmed | Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals. | 2.66e-07 | 5 | 105 | 3 | 17227909 | |
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 16025120 | ||
| Pubmed | N-domain-dependent nonphosphorylated STAT4 dimers required for cytokine-driven activation. | 5.31e-07 | 6 | 105 | 3 | 14704793 | |
| Pubmed | 5.31e-07 | 6 | 105 | 3 | 10675904 | ||
| Pubmed | GAPVD1 SPTAN1 NOL10 RAD50 DST UBR5 XPO5 SYNE2 KIF5B UTRN MED12 PPP6R3 | 6.91e-07 | 653 | 105 | 12 | 22586326 | |
| Pubmed | Expression and activation of STAT proteins during mouse retina development. | 9.28e-07 | 7 | 105 | 3 | 12634107 | |
| Pubmed | STAT heterodimers in immunity: A mixed message or a unique signal? | 9.28e-07 | 7 | 105 | 3 | 24058793 | |
| Pubmed | Physiological significance of STAT proteins: investigations through gene disruption in vivo. | 9.28e-07 | 7 | 105 | 3 | 10526573 | |
| Pubmed | 9.28e-07 | 7 | 105 | 3 | 23797472 | ||
| Pubmed | Signaling through the JAK/STAT pathway, recent advances and future challenges. | 9.28e-07 | 7 | 105 | 3 | 12039028 | |
| Pubmed | Functional association of Nmi with Stat5 and Stat1 in IL-2- and IFNgamma-mediated signaling. | 1.48e-06 | 8 | 105 | 3 | 9989503 | |
| Pubmed | Genetic polymorphisms in adaptive immunity genes and childhood acute lymphoblastic leukemia. | 1.76e-06 | 29 | 105 | 4 | 20716621 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TFEB GAPVD1 SPTAN1 CCDC6 ZCCHC14 DST LMO7 STARD9 SYNE2 CEP131 KIF5B PEAK1 UTRN | 2.06e-06 | 861 | 105 | 13 | 36931259 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | PARP11 DYNC2H1 NUP42 CCDC6 KIF7 RAD50 UBXN2B UBR5 MRPS26 SASS6 KIF5B UTRN NEURL4 PPP6R3 | 2.07e-06 | 1005 | 105 | 14 | 19615732 |
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 10781830 | ||
| Pubmed | 2.22e-06 | 9 | 105 | 3 | 23435120 | ||
| Pubmed | JAK-STAT signaling maintains homeostasis in T cells and macrophages. | 3.16e-06 | 10 | 105 | 3 | 38658806 | |
| Pubmed | 3.16e-06 | 10 | 105 | 3 | 10200816 | ||
| Pubmed | 3.16e-06 | 10 | 105 | 3 | 24069548 | ||
| Pubmed | 4.21e-06 | 407 | 105 | 9 | 12693553 | ||
| Pubmed | TCHP SPTAN1 HAUS5 KIF7 RAD50 DST QPCT CEP131 KIF5B UTRN MED12 | 4.22e-06 | 645 | 105 | 11 | 25281560 | |
| Pubmed | AKAP6 GAPVD1 HAUS5 TAOK2 FMNL3 DST LMO7 MED12L LRRC8A PPP6R3 | 4.83e-06 | 529 | 105 | 10 | 14621295 | |
| Pubmed | 5.77e-06 | 12 | 105 | 3 | 28595999 | ||
| Pubmed | Divergent Role for STAT5 in the Adaptive Responses of Natural Killer Cells. | 5.77e-06 | 12 | 105 | 3 | 33326784 | |
| Pubmed | 5.77e-06 | 12 | 105 | 3 | 14557543 | ||
| Pubmed | GAPVD1 SPTAN1 HAUS5 TNIP1 RAD50 LMO7 KIF5B PEAK1 MED12 PPP6R3 | 6.68e-06 | 549 | 105 | 10 | 38280479 | |
| Pubmed | SPTAN1 RAPGEF4 GOLGA6A CCDC6 KIF7 RAD50 TAOK2 DST UBR5 SYNE2 CEP131 KIF5B NEURL4 | 6.91e-06 | 963 | 105 | 13 | 28671696 | |
| Pubmed | Distribution of the mammalian Stat gene family in mouse chromosomes. | 7.48e-06 | 13 | 105 | 3 | 8530075 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 23151802 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 26999798 | ||
| Pubmed | Stat5 promotes metastatic behavior of human prostate cancer cells in vitro and in vivo. | 9.03e-06 | 2 | 105 | 2 | 20233708 | |
| Pubmed | Involvement of the STAT5 signaling pathway in the regulation of mouse preimplantation development. | 9.03e-06 | 2 | 105 | 2 | 16775227 | |
| Pubmed | A Mouse Model to Assess STAT3 and STAT5A/B Combined Inhibition in Health and Disease Conditions. | 9.03e-06 | 2 | 105 | 2 | 31443474 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 17447893 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 12377952 | ||
| Pubmed | A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. | 9.03e-06 | 2 | 105 | 2 | 21127177 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 16289657 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25552366 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25470773 | ||
| Pubmed | Constitutively active Stat5A and Stat5B promote adipogenesis. | 9.03e-06 | 2 | 105 | 2 | 21431790 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 16115927 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 23275557 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 28500076 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 21826656 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 11867689 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 7720707 | ||
| Pubmed | Global analysis of IL-2 target genes: identification of chromosomal clusters of expressed genes. | 9.03e-06 | 2 | 105 | 2 | 15980098 | |
| Pubmed | STAT5A and STAT5B have opposite correlations with drug response gene expression. | 9.03e-06 | 2 | 105 | 2 | 27264955 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 15340066 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 9060628 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 22159083 | ||
| Pubmed | Dystonin/Bpag1 is a necessary endoplasmic reticulum/nuclear envelope protein in sensory neurons. | 9.03e-06 | 2 | 105 | 2 | 18638474 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 20008792 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 33199496 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 9.03e-06 | 2 | 105 | 2 | 9460924 | |
| Pubmed | STAT5A/B gene locus undergoes amplification during human prostate cancer progression. | 9.03e-06 | 2 | 105 | 2 | 23660011 | |
| Pubmed | Role of Stat5 in type I interferon-signaling and transcriptional regulation. | 9.03e-06 | 2 | 105 | 2 | 12901872 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 28074064 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 36755813 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 16502315 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 12217382 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25333863 | ||
| Pubmed | A role for STAT5 in the pathogenesis of IL-2-induced glucocorticoid resistance. | 9.03e-06 | 2 | 105 | 2 | 12421978 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 9852045 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 31599926 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 19966185 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 21704724 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 10594041 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 21036145 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 10486277 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 38618957 | ||
| Pubmed | Identification of human STAT5-dependent gene regulatory elements based on interspecies homology. | 9.03e-06 | 2 | 105 | 2 | 16840779 | |
| Pubmed | The role of the STAT5 proteins in the proliferation and apoptosis of the CML and AML cells. | 9.03e-06 | 2 | 105 | 2 | 15128421 | |
| Pubmed | STAT5 deficiency in hepatocytes reduces diethylnitrosamine-induced liver tumorigenesis in mice. | 9.03e-06 | 2 | 105 | 2 | 30377054 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 23565285 | ||
| Pubmed | Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer. | 9.03e-06 | 2 | 105 | 2 | 32790723 | |
| Pubmed | Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone. | 9.03e-06 | 2 | 105 | 2 | 8732682 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 18492722 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 26717567 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 10066807 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 10835485 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 35464049 | ||
| Pubmed | The neonatal microenvironment programs innate γδ T cells through the transcription factor STAT5. | 9.03e-06 | 2 | 105 | 2 | 32281944 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 18286195 | ||
| Pubmed | Differentiating the roles of STAT5B and STAT5A in human CD4+ T cells. | 9.03e-06 | 2 | 105 | 2 | 23773921 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 8631883 | ||
| Pubmed | Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2. | 9.03e-06 | 2 | 105 | 2 | 11030348 | |
| Pubmed | Association between STAT5 polymorphisms and glioblastoma risk in Han Chinese population. | 9.03e-06 | 2 | 105 | 2 | 24878107 | |
| Pubmed | Adipocyte STAT5 deficiency does not affect blood glucose homeostasis in obese mice. | 9.03e-06 | 2 | 105 | 2 | 34818373 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 12847485 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 12835478 | ||
| Interaction | CEP63 interactions | 1.87e-08 | 179 | 99 | 10 | int:CEP63 | |
| Interaction | PCM1 interactions | KRT1 RNF31 TCHP HAUS5 SAV1 TNIP1 GOLGA6A TIPARP KRT73 KIF7 SASS6 CEP131 CCDC65 NEURL4 | 2.69e-08 | 434 | 99 | 14 | int:PCM1 |
| Interaction | NINL interactions | KRT1 TCHP DYNC2H1 HAUS5 TNIP1 EZH2 KIF7 UBR5 LMO7 PROSER3 MRPS26 ITSN2 SASS6 CEP131 | 5.25e-08 | 458 | 99 | 14 | int:NINL |
| Interaction | TNRC6A interactions | RNF31 TCHP SAV1 CCDC6 EZH2 TIPARP SYNE3 UBR5 ITSN2 SASS6 MED12 | 1.31e-07 | 280 | 99 | 11 | int:TNRC6A |
| Interaction | CPAP interactions | 2.82e-07 | 182 | 99 | 9 | int:CPAP | |
| Interaction | MED4 interactions | TCHP SPTAN1 HAUS5 KIF7 DST UBR5 MED12L QPCT SASS6 CEP131 KIF5B UTRN MED12 | 3.12e-07 | 450 | 99 | 13 | int:MED4 |
| Interaction | CEP44 interactions | 3.88e-07 | 189 | 99 | 9 | int:CEP44 | |
| Interaction | APC interactions | RNF31 SAV1 LAMA3 NUP42 CCDC6 TIPARP KIF7 SYNE3 DST UBR5 SASS6 KIF5B | 4.61e-07 | 389 | 99 | 12 | int:APC |
| Interaction | KRT19 interactions | 1.28e-06 | 282 | 99 | 10 | int:KRT19 | |
| Interaction | KRT16 interactions | 5.79e-06 | 197 | 99 | 8 | int:KRT16 | |
| Interaction | CEP135 interactions | 7.81e-06 | 272 | 99 | 9 | int:CEP135 | |
| Interaction | VIM interactions | KRT72 KRT1 TRIM15 RNF31 TCHP SPTAN1 CCDC187 TNIP1 EZH2 TIPARP KIF7 UBR5 LMO7 CEP131 KIF5B | 8.59e-06 | 804 | 99 | 15 | int:VIM |
| Interaction | SMC4 interactions | 1.01e-05 | 281 | 99 | 9 | int:SMC4 | |
| Interaction | SYNE3 interactions | TCHP TNIP1 KIF7 TAOK2 ZCCHC14 SYNE3 DST LMO7 PROSER3 SYNE2 CEP131 | 1.16e-05 | 444 | 99 | 11 | int:SYNE3 |
| Interaction | CCDC6 interactions | 1.17e-05 | 286 | 99 | 9 | int:CCDC6 | |
| Interaction | KIAA0753 interactions | 1.24e-05 | 157 | 99 | 7 | int:KIAA0753 | |
| Interaction | ODF2 interactions | 1.30e-05 | 158 | 99 | 7 | int:ODF2 | |
| Interaction | KDM1A interactions | GAPVD1 TNIP1 GOLGA6A EZH2 HESX1 TIPARP RAD50 DST UBR5 XPO5 ITSN2 CEP131 KIF5B UTRN MED12 PPP6R3 | 1.33e-05 | 941 | 99 | 16 | int:KDM1A |
| Interaction | CCP110 interactions | 1.79e-05 | 166 | 99 | 7 | int:CCP110 | |
| Interaction | PCNT interactions | 2.50e-05 | 241 | 99 | 8 | int:PCNT | |
| Interaction | HDAC1 interactions | GAPVD1 SPTAN1 TNIP1 CCDC6 EZH2 TIPARP STAT5A RAD50 XYLT2 DST UBR5 LMO7 SYNE2 CEP131 UTRN MED12 PPP6R3 | 2.60e-05 | 1108 | 99 | 17 | int:HDAC1 |
| Interaction | KRT15 interactions | 2.80e-05 | 178 | 99 | 7 | int:KRT15 | |
| Interaction | CEP290 interactions | 2.90e-05 | 179 | 99 | 7 | int:CEP290 | |
| Interaction | GAN interactions | 3.53e-05 | 253 | 99 | 8 | int:GAN | |
| Interaction | KRT18 interactions | 4.07e-05 | 419 | 99 | 10 | int:KRT18 | |
| Interaction | CCDC14 interactions | 4.21e-05 | 129 | 99 | 6 | int:CCDC14 | |
| Interaction | SPICE1 interactions | 4.39e-05 | 191 | 99 | 7 | int:SPICE1 | |
| Interaction | KRT5 interactions | 4.69e-05 | 193 | 99 | 7 | int:KRT5 | |
| Interaction | OFD1 interactions | 5.32e-05 | 347 | 99 | 9 | int:OFD1 | |
| Interaction | NUP62 interactions | 6.04e-05 | 273 | 99 | 8 | int:NUP62 | |
| Interaction | STAT3 interactions | RNF31 EZH2 HESX1 STAT4 TIPARP STAT5A STAT5B RAD50 SYNE2 PHF11 | 6.85e-05 | 446 | 99 | 10 | int:STAT3 |
| Interaction | SPATA2 interactions | 6.94e-05 | 87 | 99 | 5 | int:SPATA2 | |
| Interaction | GSK3B interactions | GAPVD1 HAUS5 CCDC6 SYNE3 DST UBXN2B UBR5 EIF2B5 MYOCD CEP131 KIF5B PEAK1 UTRN PPP6R3 | 8.60e-05 | 868 | 99 | 14 | int:GSK3B |
| Interaction | LATS2 interactions | 8.99e-05 | 289 | 99 | 8 | int:LATS2 | |
| Interaction | GSK3A interactions | GAPVD1 CCDC6 TIPARP DST UBR5 EIF2B5 CEP131 PEAK1 UTRN PPP6R3 | 9.50e-05 | 464 | 99 | 10 | int:GSK3A |
| Interaction | NUP98 interactions | 1.07e-04 | 220 | 99 | 7 | int:NUP98 | |
| Interaction | CEP128 interactions | 1.09e-04 | 297 | 99 | 8 | int:CEP128 | |
| Interaction | YWHAG interactions | TFEB GAPVD1 RNF31 SPTAN1 CCDC6 EZH2 KIF7 TAOK2 DST LMO7 STARD9 SYNE2 CEP131 KIF5B PEAK1 UTRN PPP6R3 | 1.14e-04 | 1248 | 99 | 17 | int:YWHAG |
| Interaction | FLOT1 interactions | 1.15e-04 | 475 | 99 | 10 | int:FLOT1 | |
| Interaction | SASS6 interactions | 1.34e-04 | 159 | 99 | 6 | int:SASS6 | |
| Interaction | MOB1B interactions | 1.44e-04 | 54 | 99 | 4 | int:MOB1B | |
| Interaction | NDC80 interactions | 1.52e-04 | 312 | 99 | 8 | int:NDC80 | |
| Interaction | RCOR1 interactions | 1.58e-04 | 494 | 99 | 10 | int:RCOR1 | |
| Interaction | CEP170 interactions | 1.74e-04 | 318 | 99 | 8 | int:CEP170 | |
| Interaction | CEP162 interactions | 1.81e-04 | 168 | 99 | 6 | int:CEP162 | |
| Interaction | HOOK1 interactions | 1.83e-04 | 240 | 99 | 7 | int:HOOK1 | |
| Interaction | CCDC136 interactions | 1.87e-04 | 169 | 99 | 6 | int:CCDC136 | |
| Interaction | MAP4 interactions | 1.97e-04 | 324 | 99 | 8 | int:MAP4 | |
| Interaction | LZTS2 interactions | TCHP SPTAN1 CCDC187 CCDC6 KIF7 SYNE3 CARD9 SASS6 CEP131 MED12 | 2.11e-04 | 512 | 99 | 10 | int:LZTS2 |
| Interaction | DBN1 interactions | 2.14e-04 | 417 | 99 | 9 | int:DBN1 | |
| Interaction | WWTR1 interactions | 2.33e-04 | 422 | 99 | 9 | int:WWTR1 | |
| Interaction | BICD1 interactions | 2.35e-04 | 250 | 99 | 7 | int:BICD1 | |
| Interaction | LMO7 interactions | 2.40e-04 | 177 | 99 | 6 | int:LMO7 | |
| Interaction | MCAT interactions | 2.48e-04 | 114 | 99 | 5 | int:MCAT | |
| Interaction | CALM1 interactions | AKAP6 GAPVD1 TNIP1 EZH2 DST UBR5 LMO7 SYNE2 TRPV6 PEAK1 UTRN | 2.52e-04 | 626 | 99 | 11 | int:CALM1 |
| Interaction | CEP152 interactions | 2.55e-04 | 179 | 99 | 6 | int:CEP152 | |
| Interaction | DISC1 interactions | 2.63e-04 | 429 | 99 | 9 | int:DISC1 | |
| Interaction | KRT75 interactions | 2.71e-04 | 181 | 99 | 6 | int:KRT75 | |
| Interaction | CDC5L interactions | AKAP6 CCDC185 SPTAN1 TNIP1 TIPARP RAD50 DST UBR5 XPO5 LMO7 MED12L KIF5B PPP6R3 | 2.79e-04 | 855 | 99 | 13 | int:CDC5L |
| Interaction | STAT1 interactions | 2.84e-04 | 342 | 99 | 8 | int:STAT1 | |
| Interaction | SIRT7 interactions | GAPVD1 SPTAN1 NOL10 RAD50 DST UBR5 XPO5 SYNE2 KIF5B UTRN MED12 PPP6R3 | 2.86e-04 | 744 | 99 | 12 | int:SIRT7 |
| Interaction | PHF21A interactions | 2.90e-04 | 343 | 99 | 8 | int:PHF21A | |
| Interaction | FBXO42 interactions | 2.91e-04 | 259 | 99 | 7 | int:FBXO42 | |
| Interaction | YWHAH interactions | TFEB GAPVD1 SPTAN1 SAV1 CCDC6 KIF7 ZCCHC14 DST LMO7 STARD9 SYNE2 CEP131 KIF5B PEAK1 UTRN | 3.04e-04 | 1102 | 99 | 15 | int:YWHAH |
| Interaction | USP42 interactions | 3.13e-04 | 66 | 99 | 4 | int:USP42 | |
| Interaction | KRT8 interactions | 3.22e-04 | 441 | 99 | 9 | int:KRT8 | |
| Interaction | STIL interactions | 3.52e-04 | 190 | 99 | 6 | int:STIL | |
| Interaction | KRT14 interactions | 3.72e-04 | 192 | 99 | 6 | int:KRT14 | |
| Interaction | PPIA interactions | DYNC2H1 TNIP1 NOL10 CCDC6 EZH2 KRT73 RAD50 DST STARD9 SASS6 CEP131 MED12 PPP6R3 | 4.01e-04 | 888 | 99 | 13 | int:PPIA |
| Interaction | NUP214 interactions | 4.04e-04 | 195 | 99 | 6 | int:NUP214 | |
| Interaction | RANBP2 interactions | 4.07e-04 | 361 | 99 | 8 | int:RANBP2 | |
| Interaction | MINDY4 interactions | 4.60e-04 | 73 | 99 | 4 | int:MINDY4 | |
| Interaction | PIBF1 interactions | 4.62e-04 | 200 | 99 | 6 | int:PIBF1 | |
| Interaction | TNRC6B interactions | 4.85e-04 | 282 | 99 | 7 | int:TNRC6B | |
| Interaction | EMD interactions | RNF31 TCHP SPTAN1 TNIP1 NUP42 EZH2 TIPARP TAOK2 SYNE3 LMO7 SYNE2 GORAB | 4.85e-04 | 789 | 99 | 12 | int:EMD |
| Interaction | KRT27 interactions | 4.87e-04 | 202 | 99 | 6 | int:KRT27 | |
| Interaction | PPP1CB interactions | 5.04e-04 | 469 | 99 | 9 | int:PPP1CB | |
| Interaction | KHDRBS1 interactions | 5.06e-04 | 373 | 99 | 8 | int:KHDRBS1 | |
| Interaction | SSX2IP interactions | 5.49e-04 | 288 | 99 | 7 | int:SSX2IP | |
| Interaction | FGD5 interactions | 5.54e-04 | 207 | 99 | 6 | int:FGD5 | |
| Interaction | LURAP1 interactions | 5.78e-04 | 137 | 99 | 5 | int:LURAP1 | |
| Interaction | TNIK interactions | 5.81e-04 | 381 | 99 | 8 | int:TNIK | |
| Interaction | OBI1 interactions | 6.18e-04 | 139 | 99 | 5 | int:OBI1 | |
| Interaction | MIB1 interactions | 6.33e-04 | 295 | 99 | 7 | int:MIB1 | |
| Interaction | CFH interactions | 6.38e-04 | 140 | 99 | 5 | int:CFH | |
| Interaction | FAM161B interactions | 6.51e-04 | 80 | 99 | 4 | int:FAM161B | |
| Interaction | IQGAP1 interactions | GAPVD1 SPTAN1 TNIP1 EZH2 TIPARP DST LMO7 MRPS26 KIF5B PPP6R3 | 6.53e-04 | 591 | 99 | 10 | int:IQGAP1 |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 7.60e-05 | 4 | 65 | 2 | 1252 | |
| GeneFamily | Keratins, type II | 1.22e-04 | 27 | 65 | 3 | 609 | |
| GeneFamily | EF-hand domain containing|Spectrins | 2.64e-04 | 7 | 65 | 2 | 1113 | |
| GeneFamily | SH2 domain containing | 4.78e-04 | 101 | 65 | 4 | 741 | |
| GeneFamily | VPS9 domain containing | 5.62e-04 | 10 | 65 | 2 | 928 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 6.03e-04 | 46 | 65 | 3 | 622 | |
| GeneFamily | Dynein regulatory complex | 6.85e-04 | 11 | 65 | 2 | 981 | |
| GeneFamily | EF-hand domain containing | 1.14e-03 | 219 | 65 | 5 | 863 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 1.67e-03 | 17 | 65 | 2 | 684 | |
| GeneFamily | Zinc fingers CCHC-type|RNA binding motif containing | 3.62e-03 | 25 | 65 | 2 | 74 | |
| GeneFamily | Cyclins|Mediator complex | 6.25e-03 | 33 | 65 | 2 | 1061 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 1.08e-05 | 199 | 99 | 7 | M5893 | |
| Coexpression | GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN | 1.12e-05 | 200 | 99 | 7 | M3365 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 3.37e-07 | 199 | 100 | 7 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.48e-07 | 200 | 100 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.74e-06 | 184 | 100 | 6 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.74e-06 | 184 | 100 | 6 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.49e-06 | 190 | 100 | 6 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.49e-06 | 190 | 100 | 6 | e04f47705851563515b6a66a2634cf7a574f7bda | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 6.03e-06 | 200 | 100 | 6 | a2b9d1cd291d17abddc3ee2e242121412c864b8b | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Ibsp-Inhibitory_Gad1Gad2_Htr3a.Ibsp_(Interneuron,__(candidate_CGE-derived_7))|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.32e-05 | 64 | 100 | 4 | c13a7edad4d52a955e2c2247139246522d9e4463 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Ibsp-Inhibitory_Gad1Gad2_Htr3a.Ibsp_(Interneuron,__(candidate_CGE-derived_7))-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.32e-05 | 64 | 100 | 4 | eefb4573ec4ff8efe602543ccbe555dbef1c4d54 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)-Ibsp|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.32e-05 | 64 | 100 | 4 | fcc0f3fa0b462620d031aae810a01fadb7c01202 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.63e-05 | 155 | 100 | 5 | d10cf5e922dbd3ca46660404da5aca43f181fc19 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.16e-05 | 161 | 100 | 5 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.96e-05 | 177 | 100 | 5 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.37e-05 | 180 | 100 | 5 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 5.51e-05 | 181 | 100 | 5 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.66e-05 | 182 | 100 | 5 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.66e-05 | 182 | 100 | 5 | 41b070085edba7a58b81c20aa4942d06f745acf8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.66e-05 | 182 | 100 | 5 | 5e9a67b2de0daa4fdc344b10a857d8a901ad810e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-lymphatic_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.66e-05 | 182 | 100 | 5 | b0fe042c71d6ab8c75abd7ba9d2de00b72d01c0c | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.66e-05 | 182 | 100 | 5 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.96e-05 | 184 | 100 | 5 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-05 | 185 | 100 | 5 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.27e-05 | 186 | 100 | 5 | bbb8edea8d8bdc1a469faec1563e40b1f62d7f3d | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.43e-05 | 187 | 100 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 187 | 100 | 5 | f1e9877d859369b862d4a559ec9ab9be74a67a96 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 187 | 100 | 5 | 3ffbd50b49059dcd3e23c5ac01901e4352142446 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.11e-05 | 191 | 100 | 5 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.11e-05 | 191 | 100 | 5 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.28e-05 | 192 | 100 | 5 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 7.28e-05 | 192 | 100 | 5 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.46e-05 | 193 | 100 | 5 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.46e-05 | 193 | 100 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.46e-05 | 193 | 100 | 5 | 0ef076417ffe2dd1cbc2c3d1e35c7f8522af143b | |
| ToppCell | facs-Skin-Telogen-3m-Epithelial|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 194 | 100 | 5 | 4d7fc4d0a55abb3b645116d13a983bbedc55f70c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-05 | 194 | 100 | 5 | f76808666fb875fc787751cbfd924d9be20a8192 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.65e-05 | 194 | 100 | 5 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | facs-Skin-Telogen-3m|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 194 | 100 | 5 | ba10fc5929649bb994c3f1d2ce6ca3167fa9b11b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-05 | 194 | 100 | 5 | 5c3b2b05d1e4f146551fe4c920263d8e6ca34de3 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-05 | 194 | 100 | 5 | ab9cad697f9209d2889bc02b43b502dfeb2ebfef | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-05 | 194 | 100 | 5 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | facs-Skin-Telogen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.65e-05 | 194 | 100 | 5 | bafecab8d48fc94ffd93f0d054b5f32c04b6b3f6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-05 | 194 | 100 | 5 | f5706ab6bc803606c4640ddd606617e4e797ccc9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.65e-05 | 194 | 100 | 5 | a52c5906fce43c2f72cf7e463a3d15cde06431f6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-05 | 195 | 100 | 5 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.83e-05 | 195 | 100 | 5 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.83e-05 | 195 | 100 | 5 | 22191d361af136942508f1553ff41a626ed982ad | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.83e-05 | 195 | 100 | 5 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 8.03e-05 | 196 | 100 | 5 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.03e-05 | 196 | 100 | 5 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.03e-05 | 196 | 100 | 5 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.03e-05 | 196 | 100 | 5 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.03e-05 | 196 | 100 | 5 | ab7be3858deabbd1fc44e8b9da8ff49a50bf1fb1 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.03e-05 | 196 | 100 | 5 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.03e-05 | 196 | 100 | 5 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.03e-05 | 196 | 100 | 5 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 8.03e-05 | 196 | 100 | 5 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.03e-05 | 196 | 100 | 5 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.03e-05 | 196 | 100 | 5 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.03e-05 | 196 | 100 | 5 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | hematopoetic_progenitors-CD34+_MEP_1|hematopoetic_progenitors / Lineage and Cell class | 8.22e-05 | 197 | 100 | 5 | 6172a1b98ff840d9174b1ab20ba0c202a7ef87af | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.22e-05 | 197 | 100 | 5 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.22e-05 | 197 | 100 | 5 | e4331969bd911d1ebb5453f40a7057297b5389b4 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.22e-05 | 197 | 100 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.22e-05 | 197 | 100 | 5 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.22e-05 | 197 | 100 | 5 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.22e-05 | 197 | 100 | 5 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-CD8+_Tcm|Bac-SEP / Disease, condition lineage and cell class | 8.42e-05 | 198 | 100 | 5 | 84a07dea22b7771b34118729607b48c2d75df870 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.42e-05 | 198 | 100 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 8.42e-05 | 198 | 100 | 5 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.42e-05 | 198 | 100 | 5 | 0a172c6d997c7cfbad34b56e80121bd104dee67d | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-05 | 200 | 100 | 5 | 52aef65f01b06cd98056f17977efe525aee6eb6f | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.83e-05 | 200 | 100 | 5 | 55c148238d5c80c1faa3428a917ae8075be2c145 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.83e-05 | 200 | 100 | 5 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 | |
| ToppCell | mild-NK_CD56bright|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 8.83e-05 | 200 | 100 | 5 | a195bc6784346f706d4cd5b740adac1d950ce88a | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Acta2Rgs5.Acta2_(Mural.Acta2Rgs5.Acta2)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.23e-04 | 113 | 100 | 4 | 7c5317bda7f13649af4837ca717dfdad74152f8f | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Acta2Rgs5.Acta2_(Mural.Acta2Rgs5.Acta2)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.23e-04 | 113 | 100 | 4 | 3c745f4d975475860e793f304a846b032515b334 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 1.23e-04 | 113 | 100 | 4 | d67022ae14fae91f9f21ebe8c6ab6d8d6d725bc4 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.60e-04 | 121 | 100 | 4 | 05c40fd39e6b6275f35aaad835f95a81fcbb0990 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.65e-04 | 122 | 100 | 4 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | Control-Epithelial_alveolar-Mes-Like-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.93e-04 | 127 | 100 | 4 | 556aaf88719c83f307fa50dfac151136ed05c8ad | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.11e-04 | 130 | 100 | 4 | 1720f16ac06951c3f57b6c3b0944670a571203d1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.30e-04 | 133 | 100 | 4 | 840e8240db29cd21ed9830843c0fa6d65b8f300a | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sncg|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.95e-04 | 142 | 100 | 4 | ed91d2ef4c346f7e1a5402846e2a34cee19c24d1 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.11e-04 | 144 | 100 | 4 | 04f9054895be2275eecda687a6eeb02fa5ec69b9 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.45e-04 | 148 | 100 | 4 | 10dcbdb47cac908648d9d652c8095b536db19b8a | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-CD8_TCM|Bac-SEP / Disease, Lineage and Cell Type | 3.45e-04 | 148 | 100 | 4 | 5814bfb5060bac455334eb50d2a7b1f01c0b6831 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.72e-04 | 151 | 100 | 4 | 8ba15ab24fe2e71df0a2a7511ca451ad2376bd91 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.72e-04 | 151 | 100 | 4 | f50c5ae9dae507df750df25e151b58685fec70ce | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.91e-04 | 153 | 100 | 4 | 553dff9688a1996d8f4ba16e60c683593d781389 | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cyth3_(Cyth3)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 3.91e-04 | 153 | 100 | 4 | 88ca2d2c2ab19fbee13e18951b993ee05dd30f67 | |
| ToppCell | 10x5'-Lung-Myeloid_Monocytic-Cycling_mono|Lung / Manually curated celltypes from each tissue | 4.21e-04 | 156 | 100 | 4 | 63b8cf14361b282872bc1c5b65d9fbc83e81a089 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 4.21e-04 | 156 | 100 | 4 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.31e-04 | 157 | 100 | 4 | 4183dbed6b31ebe13ef33eb19ba6d0fb4f625953 | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like-ILC3|blood / Manually curated celltypes from each tissue | 4.31e-04 | 157 | 100 | 4 | eb2520c237543ea4869d4386afc0457b111f6193 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-04 | 162 | 100 | 4 | 502ed67f6a572f10ac6e22948a1747d8214eb974 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-04 | 162 | 100 | 4 | 82e782096f89cd03d1fdf599ba727d6f23e35e2d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.85e-04 | 162 | 100 | 4 | 6bed33b17b59812646dc6a29c1d87413bad86c11 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Brinp3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.97e-04 | 163 | 100 | 4 | b0aa4a620bd58011225b42ea6dda04e3101ba342 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.97e-04 | 163 | 100 | 4 | ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8 | |
| ToppCell | Substantia_nigra-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Rgs5_(Mural.Rgs5Acta2.Rgs5)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 5.02e-04 | 69 | 100 | 3 | a157b1582401cebd222343d94086dbea876140c2 | |
| Drug | Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; PC3; HT_HG-U133A | 2.00e-07 | 199 | 98 | 9 | 6687_UP | |
| Drug | Clorgyline | 6.66e-07 | 168 | 98 | 8 | ctd:D003010 | |
| Drug | plakin | 1.46e-06 | 82 | 98 | 6 | CID000018752 | |
| Drug | Naringenine [480-41-1]; Up 200; 14.6uM; PC3; HT_HG-U133A | 2.25e-05 | 196 | 98 | 7 | 4597_UP | |
| Drug | Noscapine [128-62-1]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.40e-05 | 198 | 98 | 7 | 7204_DN | |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | 2.56e-05 | 200 | 98 | 7 | 6701_UP | |
| Disease | Sjogren's Syndrome | 8.47e-06 | 13 | 93 | 3 | C1527336 | |
| Disease | Sicca Syndrome | 8.47e-06 | 13 | 93 | 3 | C0086981 | |
| Disease | Systemic Scleroderma | 2.83e-05 | 19 | 93 | 3 | C0036421 | |
| Disease | Stomach Carcinoma | 3.87e-05 | 21 | 93 | 3 | C0699791 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 7.48e-05 | 26 | 93 | 3 | DOID:234 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | AKAP6 DYNC2H1 SPTAN1 TNIP1 EZH2 STAT4 STAT5A HOXA3 ZCCHC14 SYNE2 ITSN2 MED12 | 1.40e-04 | 1074 | 93 | 12 | C0006142 |
| Disease | level of Ceramide (d40:1) in blood serum | 5.31e-04 | 11 | 93 | 2 | OBA_2045185 | |
| Disease | Sjogren syndrome | 9.11e-04 | 60 | 93 | 3 | EFO_0000699 | |
| Disease | PR interval | 9.81e-04 | 495 | 93 | 7 | EFO_0004462 | |
| Disease | Benign neoplasm of stomach | 1.30e-03 | 17 | 93 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.30e-03 | 17 | 93 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.30e-03 | 17 | 93 | 2 | C0154060 | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 2.59e-03 | 24 | 93 | 2 | DOID:1184 (implicated_via_orthology) | |
| Disease | systemic scleroderma, systemic lupus erythematosus | 3.04e-03 | 26 | 93 | 2 | EFO_0000717, MONDO_0007915 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ERRLLLRQSQEQWQE | 301 | Q8N715 | |
| KLANQINDLRQTVIW | 521 | O71037 | |
| KLANQINDLRQTVIW | 521 | Q902F8 | |
| RLEQLRDKIRAQAWQ | 151 | A0A096LP49 | |
| LNLNKINTQWRTVLR | 56 | Q8IXS2 | |
| LEQEQEALVNRLWKR | 206 | Q16204 | |
| NAVQRLEWQLKLQEL | 2016 | Q6UB98 | |
| LLWELQQEKALLQAR | 246 | Q9H257 | |
| QEKSRWEVLQQEQRL | 141 | Q5T7V8 | |
| IMQRIQRLQADWVLE | 91 | Q16769 | |
| KQLLEDRWKSLRQQL | 1386 | Q9H0J4 | |
| QKIQERWLQDNLTLR | 1011 | Q92878 | |
| LLRWKEAEQRQLQQL | 106 | A6NNM3 | |
| LLRWKEAEQRQLQQL | 106 | A6NJZ7 | |
| VLQRWLQQTIKERAL | 196 | Q9NYA3 | |
| EWERIRRQELLNQKN | 461 | Q9NZM3 | |
| RILQILRVQNQFLWE | 491 | Q7Z3E1 | |
| NKILRNTIQWLENEL | 351 | P33176 | |
| NLNNEWTLDKLRQRL | 406 | Q8IWT6 | |
| QQWQLLDRILQQIVL | 396 | Q86T65 | |
| IKRILQNLEQWTLRQ | 1311 | Q86YW9 | |
| KRESQLLLNRIRTWQ | 1996 | Q16787 | |
| QNQVLETKWELLQQL | 156 | Q86Y46 | |
| NLLNLTERQIKIWFQ | 226 | O43365 | |
| WQELNQLTIDRQQKL | 4606 | Q03001 | |
| ENAQRLRLQDRIWII | 201 | Q9Y5R4 | |
| WIAKQQRINLDRLII | 46 | Q14C86 | |
| LTWEQRQLQKELQRL | 46 | Q86UF4 | |
| QLRKNQQLQRFIQWL | 696 | Q13144 | |
| RQKILERTEILNQEW | 46 | Q15910 | |
| ERTEILNQEWKQRRI | 51 | Q15910 | |
| LEQQNQVLQTKWELL | 201 | P04264 | |
| QRNTLLQNWLDIKRT | 1686 | Q9H792 | |
| LAQKLNLEEDRIQIW | 141 | Q9UBX0 | |
| WRLAQAQQKIRELAI | 701 | Q2M1P5 | |
| QLVIERERKWEQQLQ | 1341 | Q8WWI1 | |
| RQRIKRILQNLDQWT | 1341 | Q93074 | |
| RLRQQDERLWQQETL | 286 | A6NEM1 | |
| LRQQDERLWQQETLR | 371 | A6NI86 | |
| LNLTERQIKIWFQNR | 231 | P31249 | |
| LRELQAKQQRILHWR | 376 | O94927 | |
| AWVEEVRKQRRLLQQ | 556 | Q9BSC4 | |
| KLANQINDLRQTVIW | 1281 | P63135 | |
| LTWKLQQEQRQVEEL | 531 | Q8IZQ8 | |
| IWKRNNIILNNLDLE | 281 | Q8N475 | |
| LINQWRNRVNELKSL | 181 | O15504 | |
| IKRIQRIQNLDLWEF | 166 | Q9NR21 | |
| QWEIDRNSIQLLKRL | 226 | P42685 | |
| LMNIDLLRQQQRWKD | 706 | Q8NCM8 | |
| LLRQQQRWKDGLQEL | 711 | Q8NCM8 | |
| KLANQINDLRQTVIW | 521 | P61570 | |
| KLANQINDLRQTVIW | 521 | Q69384 | |
| QRNKWQQQELIAELR | 961 | Q8IVF7 | |
| GWLQRLQESLQQRAL | 21 | P48664 | |
| KLANQINDLRQTVIW | 521 | Q902F9 | |
| RRQQWKLFQELLEQD | 576 | P57679 | |
| LRIDNLWQFENLRKL | 56 | Q9H069 | |
| RRSIQKLIEWENNRL | 171 | Q5VXU3 | |
| ITWLNKELNENQLVR | 471 | Q6UVJ0 | |
| WKLLRQDQQSIILVN | 151 | Q9HBV2 | |
| NTLKQQLELERQAWE | 856 | Q9UPN4 | |
| QLLVQVRIDFLNRQW | 1171 | Q96JN8 | |
| WKLRQLLQATLRELQ | 401 | Q0P6D2 | |
| WRLQQVEEKILQKRA | 841 | O94851 | |
| VIARLNLNEVEKQWR | 86 | Q9NZG7 | |
| VQAWAQRKEREVLQL | 146 | Q9BYN8 | |
| VLKLENEIRQAQVQW | 11 | Q8N8U3 | |
| NQWLRRNIKNLLQQL | 801 | Q9Y5W8 | |
| QKILSEELQQNRRWN | 156 | A4D263 | |
| WNRLQEINILWQELL | 521 | P46939 | |
| LNNKRRVIRLVLQWA | 571 | Q8WZA2 | |
| QLWLRIQELEMQARV | 311 | P19484 | |
| WQLRQQKLQEEQRKQ | 91 | Q86TS9 | |
| TRSNWNLRLQNLIKN | 91 | A0A0A0MS02 | |
| QNLLLWLASAKNRRQ | 6671 | Q8WXH0 | |
| LLRSRGAWEQQIKQL | 326 | Q6ZMZ3 | |
| RWQLRSLLLQELAQK | 651 | A0AVI2 | |
| LLRWKEAEQRQLQQL | 106 | Q9UFD9 | |
| EWLLRQKEQLQQCQA | 611 | Q9UL54 | |
| IILDDELIQWKRRQQ | 246 | P51692 | |
| KLAEIIWQNRQQIRR | 281 | P51692 | |
| QLQRKALLQELQRWA | 411 | Q9UIF7 | |
| ILYQWRQRRKLEQAQ | 286 | Q2NL68 | |
| WISQQIKENQQCLLR | 681 | Q9P2P6 | |
| RRRQLLASLQLQEWK | 1306 | Q9NRC6 | |
| IILDDELIQWKRRQQ | 246 | P42229 | |
| KLAEIIWQNRQQIRR | 281 | P42229 | |
| LQRQIKRQHSWILRA | 871 | Q13023 | |
| DWTALRLQKLLQDNN | 936 | Q96EP0 | |
| LEQQRSELLEVNKQW | 306 | Q15025 | |
| LLTELENRKQRQQWY | 361 | Q9H4B6 | |
| NEVLNRQIQKEIWRI | 641 | Q9Y2H5 | |
| WKQLKENLQLVRQRN | 621 | Q8WYP3 | |
| WVNQQREDIERQRKL | 331 | Q9UKI8 | |
| NNNLLRQQLKWLICE | 91 | Q8WVN8 | |
| ENQLQDVQILLKLWS | 136 | Q14CS0 | |
| LIEELQDWKRRQQIA | 231 | Q14765 | |
| NSIKELNERWRSLQQ | 1206 | Q13813 | |
| ERNWSQEKLQLVERL | 841 | O94964 | |
| LLLARLRELEQQIWK | 186 | Q9C019 | |
| LRLWDIQHQLSIQRI | 86 | Q8IV35 | |
| RLSQKWQVINQRSLL | 926 | Q9HAV4 | |
| QSRDEQNLLQQKRIW | 71 | Q9H1D0 | |
| QENLLKQRWELERLE | 241 | Q9BT92 | |
| QRWQQLKEEIELLQD | 291 | Q9UIL8 | |
| QEQNGILDWLRKLRL | 296 | Q8WYQ9 | |
| IQRWLAERKQQKEQL | 1051 | Q14139 | |
| DVLNWLNEEKIIQRL | 181 | Q5H9R7 | |
| LVDNNLRVTNWNRKL | 451 | Q9H1B5 | |
| QLALERVLQDWNALK | 1326 | O95071 | |
| QVLETKWNLLQQLDL | 151 | Q14CN4 | |
| EMQWRLQVNRLQELI | 221 | Q96P71 |